Cachexia
Cachexia
Explore linked clinical trials. Standard reference: MESH:M000312665 results ยท Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hospital-Based Prospective Cohort of Malnutrition Under 6-Month Study (HOSPIC-6-Study) | Body Weight, Body Weight Changes, Cachexia, Infant Malnutrition, Infant Nutrition Disorders, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, nutritional deficiency disease, nutritional disorder | Recruiting | Not stated | 2026-10-09 | NCT07831343 | |
| A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss | Anorexia, Body Weight, Body Weight Changes, Cachexia, Fatigue, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Thoracic Neoplasms, Weight Loss, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07663630 | |
| A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue | Anorexia, Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Fatigue, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Weight Loss, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-09-25 | NCT06989437 | |
| Increasing the Coverage of Severe Acute Malnutrition (SAM) Treatment in Ethiopia | Body Weight, Body Weight Changes, Cachexia, Child Malnutrition, Child Nutrition Disorders, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Severe Acute Malnutrition, Signs and Symptoms, Thinness, Weight Loss, nutritional deficiency disease, nutritional disorder | Recruiting | Not applicable | 2026-09-24 | NCT06380504 | |
| Visugromab in Cachexia International Trial | Anorexia, Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Weight Loss, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-09-22 | NCT07112196 | |
| Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life | Atrophy, Body Weight, Body Weight Changes, Cachexia, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Thinness, Weight Loss, muscular atrophy, nervous system disorder | Recruiting | Not applicable | 2026-09-15 | NCT07255001 | |
| Effectiveness of Small-Quantity vs Medium-Quantity Lipid-Based Nutrient Supplements for Prevention of Undernutrition in Young Children | Body Weight, Body Weight Changes, Cachexia, Hemic and Lymphatic Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, anemia, hematologic disorder, hereditary endocrine growth disease, nutritional deficiency disease, nutritional disorder | Recruiting | Not applicable | 2026-09-03 | NCT07451951 | |
| A Multimodal Integrated Intervention for Kidney Cachexia | Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss | Recruiting | Not applicable | 2026-08-26 | NCT07107087 | |
| A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya | Body Weight, Body Weight Changes, Cachexia, Child Malnutrition, Child Nutrition Disorders, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, nutritional disorder | Recruiting | Not applicable | 2026-08-19 | NCT06842732 | |
| Choline to Improve Malnutrition and Enhance Cognition | Body Weight, Body Weight Changes, Cachexia, Cognition Disorders, Cognitive Dysfunction, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Severe Acute Malnutrition, Signs and Symptoms, Thinness, Weight Loss, cognitive disorder, kwashiorkor, nutritional deficiency disease, nutritional disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-08-13 | NCT06154174 | |
| Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma | Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Wasting Syndrome, Weight Loss, endocrine system disorder, malignant endocrine neoplasm, metabolic disease, neoplasm, nutritional disorder, pancreas disorder, pancreatic adenocarcinoma, pancreatic neoplasm | Recruiting | Not stated | 2026-07-23 | NCT05376592 | |
| Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer | Anorexia, Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Weight Loss, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, esophageal disorder, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-07-16 | NCT05705492 | |
| Regular Growth Monitoring (RGM) of Young Children in Guinea-Bissau | Body Weight, Body Weight Changes, Cachexia, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Severe Acute Malnutrition, Signs and Symptoms, Thinness, Weight Loss, nutritional deficiency disease, nutritional disorder | Active, not recruiting | Not applicable | 2026-07-15 | NCT07584395 | |
| Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy | Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-07-15 | NCT06937177 | |
| Expanding Coverage of Severe Acute Malnutrition (SAM) Treatment in Kenya | Body Weight, Body Weight Changes, Cachexia, Child Malnutrition, Child Nutrition Disorders, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Severe Acute Malnutrition, Signs and Symptoms, Thinness, Weight Loss, nutritional deficiency disease, nutritional disorder | Recruiting | Not applicable | 2026-07-15 | NCT06441305 | |
| Ruxolitinib for Cancer Cachexia | Anorexia, Atrophy, Body Weight, Body Weight Changes, Cachexia, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Thoracic Neoplasms, Weight Loss, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, muscular atrophy, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Early phase 1 | 2026-07-07 | NCT04906746 | |
| Routine Evaluation of People Living With Cancer | Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, neoplasm | Recruiting | Not stated | 2026-07-07 | NCT04406662 | |
| Resting Energy Expenditure in Palliative Cancer Patients | Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, cancer, neoplasm | Active, not recruiting | Not stated | 2026-06-29 | NCT06206785 | |
| Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia | Atrophy, Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Thinness, Weight Loss, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, muscular atrophy, neoplasm, nervous system disorder, pancreas disorder, pancreatic neoplasm | Recruiting | Not stated | 2026-06-26 | NCT07670286 | |
| Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101 | Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, neoplasm | Recruiting | Phase 2 | 2026-06-17 | NCT07168226 | |
| A Phase I Clinical Study to Evaluate the Efficacy and Safety of GB18 Injection in Patients With Tumor Cachexia | Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, neoplasm | Recruiting | Phase 1 | 2026-06-12 | NCT07519564 | |
| Telemedicine Nutritional Counseling for Cancer Cachexia in Pakistan | Atrophy, Body Weight, Body Weight Changes, Cachexia, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Thinness, Weight Loss, muscular atrophy, neoplasm, nervous system disorder | Active, not recruiting | Not applicable | 2026-06-08 | NCT07606417 | |
| Effectiveness of Positive Deviance/Hearth in Treating Uncomplicated Moderate Acute Malnutrition in Children 6-59 Months in Mymensingh Division, Bangladesh | Body Weight, Body Weight Changes, Cachexia, Disease Attributes, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Signs and Symptoms, Thinness, Weight Loss, nutritional deficiency disease, nutritional disorder | Not yet recruiting | Not applicable | 2026-05-15 | NCT07591064 | |
| A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors | Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss | Recruiting | Early phase 1 | 2026-05-15 | NCT06736275 | |
| Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD) | Atrophy, Body Weight, Body Weight Changes, Bone Diseases, Metabolic, Cachexia, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Male Urogenital Diseases, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Osteopenia, Overweight, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Thinness, Urogenital Diseases, Weight Loss, bone disorder, cardiovascular disorder, chronic renal failure syndrome, cystic fibrosis, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, hereditary disease, hyperparathyroidism, hypoparathyroidism, kidney disorder, kidney failure, lung disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, muscular atrophy, musculoskeletal system disorder, myocardial ischemia, nervous system disorder, nutritional disorder, obesity disorder, osteoporosis, overnutrition, pancreas disorder, parathyroid gland disorder, respiratory system disorder, urinary system disorder, vascular disorder | Recruiting | Not stated | 2026-05-07 | NCT07083557 |